Yüklüyor......
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Objective: To study the safety and efficacy of the cholinesterase inhibitor donepezil in patients with Parkinson's disease (PD) and cognitive impairment. Methods: This was a double blind, randomised and placebo controlled, crossover study in which 14 patients with PD and cognitive impairment re...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Group
2002
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1737925/ https://ncbi.nlm.nih.gov/pubmed/12023410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.72.6.708 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|